Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Bratkowski

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Scientific Reports|June 16, 2018
An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 InhibitorsMatthew Bratkowski, Xin Yang, Xin Liu
The Journal of Biological Chemistry|June 14, 2017
Polycomb repressive complex 2 in an autoinhibited stateMatthew Bratkowski, Xin Yang, Xin Liu
The Journal of Biological Chemistry|November 22, 2017
Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talkMatthew Bratkowski, Ilona Christy Unarta, Lizhe Zhu, et al.
Communications Chemistry|October 29, 2023
Cryo-EM structure of human PAPP-A2 and mechanism of substrate recognitionJanani Sridar, Amirhossein Mafi, Russell A Judge, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Structural basis of MPL activation by thrombopoietinAmirhossein Mafi, Matthew Bratkowski, Jiefei Geng, et al.
Nature Communications|February 28, 2024
Structure of the p53 degradation complex from HPV16John C K Wang, Hannah T Baddock, Amirhossein Mafi, et al.
Cell Reports|August 7, 2020
Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1Matthew Bratkowski, Tian Xie, Desiree A Thayer, et al.
Neuron|September 10, 2022
Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and diseaseMatthew Bratkowski, Thomas C Burdett, Jean Danao, et al.
Communications Chemistry|August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexQi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Scientific Reports|June 16, 2018
An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 InhibitorsMatthew Bratkowski, Xin Yang, Xin Liu
The Journal of Biological Chemistry|June 14, 2017
Polycomb repressive complex 2 in an autoinhibited stateMatthew Bratkowski, Xin Yang, Xin Liu
The Journal of Biological Chemistry|November 22, 2017
Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talkMatthew Bratkowski, Ilona Christy Unarta, Lizhe Zhu, et al.
Communications Chemistry|October 29, 2023
Cryo-EM structure of human PAPP-A2 and mechanism of substrate recognitionJanani Sridar, Amirhossein Mafi, Russell A Judge, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Structural basis of MPL activation by thrombopoietinAmirhossein Mafi, Matthew Bratkowski, Jiefei Geng, et al.
Nature Communications|February 28, 2024
Structure of the p53 degradation complex from HPV16John C K Wang, Hannah T Baddock, Amirhossein Mafi, et al.
Cell Reports|August 7, 2020
Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1Matthew Bratkowski, Tian Xie, Desiree A Thayer, et al.
Neuron|September 10, 2022
Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and diseaseMatthew Bratkowski, Thomas C Burdett, Jean Danao, et al.
Communications Chemistry|August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexQi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.
Pageof 1